相关实验视频

Updated: May 20, 2025

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.2K

在黑色素瘤中使用新辅助免疫检查点阻塞的发现机会

Uma Nair1, Emily Rakestraw1, Georgia M Beasley1

  • 1Department of Surgery, Duke University, Durham, NC 27710, USA.

International journal of molecular sciences
|March 27, 2025
PubMed
概括

新辅助免疫疗法为晚期黑色素瘤患者提供了改善的无事件生存率. 了解瘤微环境和血液标志物对于预测免疫检查点抑制剂的反应和个性化治疗至关重要.

关键词:
免疫疗法 免疫疗法淋巴结中的淋巴结.黑色素瘤是一种黑色素瘤.这是一种新辅助剂.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450